"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're committed to delivering the care you need. With options for face-to-face, virtual visits or phone appointments in adherence with federal and state executive orders and guidance. Mayo Clinic treats more than 30,000 people with blood diseases and 150,000 people with cancer. Mayo Clinic hematologists work in collaboration with teams of top experts from virtually every medical and surgical specialty for the best possible care of adults and children with blood diseases, including various cancers of the blood and bone marrow."

During the past decade, Mayo Clinic - Division Of Hematology/oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic - Division Of Hematology/oncology" are "Castration-Resistant Prostatic Cancer" (1 trials), "Prostatic Neoplasms" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Mayo Clinic - Division Of Hematology/oncology" in a lesser frequency.

Most popular intervention types in "Mayo Clinic - Division Of Hematology/oncology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abiraterone Acetate" (1 trials), "Abiraterone acetate 1000 mg" (1 trials), "Androgen Deprivation Therapy (ADT)" (1 trials) and "Apalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic - Division Of Hematology/oncology" are 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mayo Clinic - Division Of Hematology/oncology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mayo Clinic - Division Of Hematology/oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic - Division Of Hematology/oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".